therapeutic action: rapid-acting antidepressant effects

Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial

This study examined how psilocybin mushroom therapy works for treating depression when combined with talk therapy. Participants received a placebo pill followed by psilocybin four weeks later, both times as part of psychological treatment. The research found that people who received psilocybin showed greater improvements in their ability to accept difficult thoughts and emotions and live according to their values, and these improvements were linked to feeling less depressed.

Read More »

Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon

Psilocybin, the active compound in certain mushrooms, shows promise as a treatment for depression and anxiety in cancer patients, particularly those nearing end of life. Oregon legalized supervised psilocybin therapy in 2020, making it the first U.S. state to do so. While clinical research shows the treatment can rapidly reduce depression and improve quality of life, the actual rollout has faced challenges including regulatory hurdles, lack of professional standards, and unequal geographic access.

Read More »
Scroll to Top